{
    "2020-09-16": [
        [
            {
                "time": "2020-10-27",
                "original_text": "Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting",
                "features": {
                    "keywords": [
                        "LY-CoV555",
                        "proof of concept",
                        "COVID-19",
                        "neutralizing antibody"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Eli Lilly Posts Positive Data On Covid-19 Treatment In Phase 2 Trials",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "Phase 2 Trials",
                        "Positive Data"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Lilly's Coronavirus Antibody Treatment Found Effective, Safe In Mild-To-Moderate Patients",
                "features": {
                    "keywords": [
                        "Coronavirus",
                        "Antibody Treatment",
                        "Effective",
                        "Safe"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Eli Lilly Reports Success With COVID-19 Neutralizing Antibody Treatment",
                "features": {
                    "keywords": [
                        "Success",
                        "Neutralizing Antibody",
                        "Treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Pfizer",
                        "Hospitalized",
                        "Covid",
                        "Treatments"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Coronavirus update: Operation Warp Speed readies for vaccine as CDC tries to manage expectations",
                "features": {
                    "keywords": [
                        "Operation Warp Speed",
                        "vaccine",
                        "CDC",
                        "expectations"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Dow Jones Rallies 200 Points Ahead Of Fed; Stocks Mixed As Nasdaq Falters",
                "features": {
                    "keywords": [
                        "Dow Jones",
                        "Rallies",
                        "Fed",
                        "Stocks Mixed",
                        "Nasdaq"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Eli Lilly Says Antibody Lowers Risk of Hospitalization for Mild COVID-19 Patients",
                "features": {
                    "keywords": [
                        "Antibody",
                        "Lowers Risk",
                        "Hospitalization",
                        "Mild COVID-19"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Lilly Drug Gets Fast Track to Improve Heart Attack Outcome",
                "features": {
                    "keywords": [
                        "Lilly Drug",
                        "Fast Track",
                        "Heart Attack"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Eli Lilly Says Covid-19 Treatment Reduces Hospitalizations",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "Treatment",
                        "Reduces",
                        "Hospitalizations"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Shares of Lilly gain as it discloses promising interim findings for COVID-19 antibody treatment",
                "features": {
                    "keywords": [
                        "Shares",
                        "Lilly",
                        "gain",
                        "promising interim findings",
                        "COVID-19",
                        "antibody treatment"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "Lilly says antibody reduces need for hospitalization for moderate COVID-19 patients",
                "features": {
                    "keywords": [
                        "antibody",
                        "reduces",
                        "hospitalization",
                        "moderate COVID-19"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-27",
                "original_text": "The Argus Dividend Growth Portfolio",
                "features": {
                    "keywords": [
                        "Argus",
                        "Dividend Growth Portfolio"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}